Aktis Oncology Inc.
Organization details
- Legal name
- Aktis Oncology Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- AKTS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002035832
- EIN
- 85-2584233
Board of directors
-
Glenn Gormley · DirectorSince 2026
-
Helen Susan Kim · DirectorSince 2026
-
Ken Herrmann · DirectorSince 2026
-
Lloyd Mitchell Segal · DirectorSince 2026
- Since 2026
-
Matthew Roden · Director · President and CEOSince 2026
-
Michael A. Sherman · DirectorSince 2026
-
Oleg Nodelman · DirectorSince 2026
-
Todd Foley · DirectorSince 2026
Chief executives
Board connections
4 of this board's directors also sit on 9 other boards. 9 are in the same sector.
-
Alaunos Therapeutics Inc. Same sectorvia Mary Thistle
-
AnaptysBio Inc. Same sectorvia Oleg Nodelman
-
Cullinan Therapeutics Inc. Same sectorvia Mary Thistle
-
Entrada Therapeutics Inc. Same sectorvia Mary Thistle
-
Nuvation Bio Inc. Same sectorvia Oleg Nodelman
-
Prothena Corporation plc Same sectorvia Helen Susan Kim
-
Q32 Bio Inc. Same sectorvia Mary Thistle
-
Werewolf Therapeutics Inc. Same sectorvia Michael A. Sherman
-
Zymeworks Inc. Same sectorvia Oleg Nodelman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $114,311,628
- 9 purchases by 6 insiders
- Sold, last 12 months
- $3,231,414
- 11 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Czibere Akos Officer (Chief Medical Officer) | Option exercise | +12,500 | $4.95 | $61,875 |
| Sep 23, 2026 | Czibere Akos Officer (Chief Medical Officer) | Open-market sale | −5,099 | $20.19 | $102,949 |
| Sep 23, 2026 | Czibere Akos Officer (Chief Medical Officer) | Open-market sale | −7,401 | $21.03 | $155,643 |
| Jul 20, 2026 | Ken Herrmann Director | Option exercise | +3,506 | $0.08 | $280 |
| Jul 20, 2026 | Ken Herrmann Director | Option exercise | +1,350 | $1.91 | $2,579 |
| Jul 20, 2026 | Ken Herrmann Director | Open-market sale | −3,506 | $24.56 | $86,107 |
| Jul 20, 2026 | Ken Herrmann Director | Open-market sale | −1,350 | $24.56 | $33,156 |
| Jul 17, 2026 | Ken Herrmann Director | Option exercise | +3,065 | $0.08 | $245 |
| Jul 17, 2026 | Ken Herrmann Director | Open-market sale | −3,065 | $25.21 | $77,269 |
| Jul 8, 2026 | Czibere Akos Officer (Chief Medical Officer) | Option exercise | +50,000 | $4.95 | $247,500 |
| Jul 8, 2026 | Ron-Bigger Shulamit Officer (Chief Operating Officer) | Option exercise | +50,000 | $3.66 | $183,000 |
| Jul 8, 2026 | Czibere Akos Officer (Chief Medical Officer) | Open-market sale | −14,800 | $27.13 | $401,524 |
| Jul 8, 2026 | Ron-Bigger Shulamit Officer (Chief Operating Officer) | Open-market sale | −15,800 | $27.13 | $428,654 |
| Jul 8, 2026 | Czibere Akos Officer (Chief Medical Officer) | Open-market sale | −30,829 | $27.95 | $861,671 |
| Jul 8, 2026 | Ron-Bigger Shulamit Officer (Chief Operating Officer) | Open-market sale | −30,000 | $27.94 | $838,200 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Aktis Oncology Inc.
Who is the CEO of Aktis Oncology Inc.?
Matthew Roden has been Aktis Oncology Inc.'s President and CEO since January 2026.
How many directors are on Aktis Oncology Inc.'s board?
Aktis Oncology Inc.'s board has 9 directors: Glenn Gormley, Helen Susan Kim, Ken Herrmann, Lloyd Mitchell Segal, Mary Thistle, Matthew Roden, Michael A. Sherman, Oleg Nodelman and Todd Foley.
Are Aktis Oncology Inc. insiders buying or selling shares?
Over the last 12 months, Aktis Oncology Inc. insiders bought $114.3 million of shares in 9 purchases and sold $3.2 million of shares in 11 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="aktis-oncology-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.